ResearcherMie UniversityActive in the last 2 years
Benson Kaluba
Matched on ORCID iD 0000-0003-1057-3251; OpenAlex author ID A5081700390. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 4 papers
Papers 6
- Long-term survival analysis based on tumor location in patients with pancreatic ductal adenocarcinoma who underwent pancreatectomy following neoadjuvant chemor… Co-author DOI 10.1007/s00423-025-03609-8↗
- Surgical strategies for locally advanced pancreatic cancer following gemcitabine plus S-1-based chemoradiotherapy. Co-author DOI 10.1016/j.suronc.2025.102269↗
- Tumor Budding Is an Independent Adverse Prognostic Factor of Pancreatic Ductal Adenocarcinoma Patients Treated by Resection After Preoperative Chemoradiotherap… Co-author DOI 10.1097/mpa.0000000000002440↗
- Impact of Surgical Resection After Induction Gemcitabine Plus S-1-Based Chemoradiotherapy in Patients with Locally Advanced Pancreatic Ductal Adenocarcinoma: A… Co-author DOI 10.3390/cancers17061048↗
- Extrapancreatic extension is a better adverse prognostic factor than tumor size in patients with localized pancreatic ductal adenocarcinoma treated with chemor… Co-author DOI 10.1016/j.hpb.2023.06.015↗
- Involvement of superior mesenteric vein and superior mesenteric artery is adverse prognostic factors in patients with localized pancreatic ductal adenocarcinom… Co-author DOI 10.21203/rs.3.rs-2229927/v1↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yasuhiro Murata · 6 shared papers, 2022–2025 · strength 1.14
- Paper Impact of Surgical Resection After Induction Gemcitabine Plus S-1-Based Chemoradiotherapy in Patients with Locally Adva… DOI 10.3390/cancers17061048↗
- Paper Long-term survival analysis based on tumor location in patients with pancreatic ductal adenocarcinoma who underwent pan… DOI 10.1007/s00423-025-03609-8↗
- Paper Surgical strategies for locally advanced pancreatic cancer following gemcitabine plus S-1-based chemoradiotherapy. DOI 10.1016/j.suronc.2025.102269↗
- Aoi Hayasaki · 6 shared papers, 2022–2025 · strength 1.14
- Paper Impact of Surgical Resection After Induction Gemcitabine Plus S-1-Based Chemoradiotherapy in Patients with Locally Adva… DOI 10.3390/cancers17061048↗
- Paper Long-term survival analysis based on tumor location in patients with pancreatic ductal adenocarcinoma who underwent pan… DOI 10.1007/s00423-025-03609-8↗
- Paper Surgical strategies for locally advanced pancreatic cancer following gemcitabine plus S-1-based chemoradiotherapy. DOI 10.1016/j.suronc.2025.102269↗
- Takahiro Ito · 6 shared papers, 2022–2025 · strength 1.14
- Paper Impact of Surgical Resection After Induction Gemcitabine Plus S-1-Based Chemoradiotherapy in Patients with Locally Adva… DOI 10.3390/cancers17061048↗
- Paper Long-term survival analysis based on tumor location in patients with pancreatic ductal adenocarcinoma who underwent pan… DOI 10.1007/s00423-025-03609-8↗
- Paper Surgical strategies for locally advanced pancreatic cancer following gemcitabine plus S-1-based chemoradiotherapy. DOI 10.1016/j.suronc.2025.102269↗
- Shugo Mizuno · 6 shared papers, 2022–2025 · strength 1.14
- Paper Impact of Surgical Resection After Induction Gemcitabine Plus S-1-Based Chemoradiotherapy in Patients with Locally Adva… DOI 10.3390/cancers17061048↗
- Paper Long-term survival analysis based on tumor location in patients with pancreatic ductal adenocarcinoma who underwent pan… DOI 10.1007/s00423-025-03609-8↗
- Paper Surgical strategies for locally advanced pancreatic cancer following gemcitabine plus S-1-based chemoradiotherapy. DOI 10.1016/j.suronc.2025.102269↗
- Naohisa Kuriyama · 6 shared papers, 2022–2025 · strength 1.14
- Paper Impact of Surgical Resection After Induction Gemcitabine Plus S-1-Based Chemoradiotherapy in Patients with Locally Adva… DOI 10.3390/cancers17061048↗
- Paper Long-term survival analysis based on tumor location in patients with pancreatic ductal adenocarcinoma who underwent pan… DOI 10.1007/s00423-025-03609-8↗
- Paper Surgical strategies for locally advanced pancreatic cancer following gemcitabine plus S-1-based chemoradiotherapy. DOI 10.1016/j.suronc.2025.102269↗
- Masashi Kishiwada · 6 shared papers, 2022–2025 · strength 1.14
- Paper Impact of Surgical Resection After Induction Gemcitabine Plus S-1-Based Chemoradiotherapy in Patients with Locally Adva… DOI 10.3390/cancers17061048↗
- Paper Long-term survival analysis based on tumor location in patients with pancreatic ductal adenocarcinoma who underwent pan… DOI 10.1007/s00423-025-03609-8↗
- Paper Surgical strategies for locally advanced pancreatic cancer following gemcitabine plus S-1-based chemoradiotherapy. DOI 10.1016/j.suronc.2025.102269↗
- Kazuyuki Gyoten · 5 shared papers, 2022–2025 · strength 0.90
- Paper Long-term survival analysis based on tumor location in patients with pancreatic ductal adenocarcinoma who underwent pan… DOI 10.1007/s00423-025-03609-8↗
- Paper Surgical strategies for locally advanced pancreatic cancer following gemcitabine plus S-1-based chemoradiotherapy. DOI 10.1016/j.suronc.2025.102269↗
- Paper Tumor Budding Is an Independent Adverse Prognostic Factor of Pancreatic Ductal Adenocarcinoma Patients Treated by Resec… DOI 10.1097/mpa.0000000000002440↗
- Toru Shinkai · 4 shared papers, 2022–2025 · strength 0.69
- Paper Surgical strategies for locally advanced pancreatic cancer following gemcitabine plus S-1-based chemoradiotherapy. DOI 10.1016/j.suronc.2025.102269↗
- Paper Tumor Budding Is an Independent Adverse Prognostic Factor of Pancreatic Ductal Adenocarcinoma Patients Treated by Resec… DOI 10.1097/mpa.0000000000002440↗
- Paper Extrapancreatic extension is a better adverse prognostic factor than tumor size in patients with localized pancreatic d… DOI 10.1016/j.hpb.2023.06.015↗
- Shuji Isaji · 2 shared papers, 2022–2023 · strength 0.28
- Paper Extrapancreatic extension is a better adverse prognostic factor than tumor size in patients with localized pancreatic d… DOI 10.1016/j.hpb.2023.06.015↗
- Paper Involvement of superior mesenteric vein and superior mesenteric artery is adverse prognostic factors in patients with l… DOI 10.21203/rs.3.rs-2229927/v1↗
- Miki Usui · 1 shared paper, 2025 · strength 0.20
- Masatoshi Watanabe · 1 shared paper, 2025 · strength 0.20
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.